Anthropic Targets October 2026 IPO, Taps Goldman Sachs and JPMorgan as Lead Underwriters

Anthropic is in active discussions about an initial public offering that executives and advisors are targeting for October 2026, according to reporting by Bloomberg and the Financial Times. The company has engaged Goldman Sachs, JPMorgan, and Morgan Stanley to explore the listing, and has retained Wilson Sonsini Goodrich & Rosati, the law firm behind Google's and LinkedIn's IPOs, for structural and regulatory preparation. No S-1 has been filed with the SEC, and the timeline remains subject to market conditions, but the conversations represent the most concrete steps Anthropic has taken toward going public.

The October target would put Anthropic among a cluster of major AI companies moving toward public markets in the second half of 2026. OpenAI has filed confidentially with Goldman Sachs and Morgan Stanley as its own underwriters, and SpaceX has renewed internal conversations about a partial listing. The overlap in advisory relationships underscores how compressed the IPO window has become: all three companies are trying to reach public markets before conditions shift, and all three are drawing on the same small pool of banks with the credibility to handle nine- and ten-figure raises.

The Revenue Case for Going Public Now

The logic behind an October listing is straightforward: Anthropic's revenue growth gives it a narrative that public-market investors rarely see at this scale. The company ended 2025 at roughly $9 billion in annualized revenue and reported $30 billion by March 2026, a 233% increase in under 90 days. Enterprise accounts spending more than $1 million annually doubled within that same two-month window. Those numbers, if they hold through a second quarter that Anthropic has not yet reported, would give underwriters a compelling growth story to take on the road.

The revenue acceleration is tied to the adoption of Claude's coding and agentic products, which have driven multi-year commitments from enterprises including KPMG, PwC, Bristol Myers Squibb, and SAP. Each of those partnerships was announced within a roughly six-week period in April and May 2026, a pace of enterprise deal-making that suggests Anthropic's sales organization has found a repeatable motion. That consistency matters to institutional investors pricing a public listing, who want evidence that revenue growth is structural rather than concentrated in a few early adopters.

The company's unit economics have also improved as compute costs have fallen. Anthropic's 1.8 billion dollar inference deal with Akamai, signed in May 2026, is designed to reduce per-token cost at scale, which would widen gross margins as volumes grow. Higher margins on growing revenue is the profile public-market technology investors price most aggressively.

"Anthropic executives had discussed an IPO as soon as Q4 2026 and bankers expected the offering could raise more than $60 billion." Bloomberg, May 2026

What Bankers Are Pricing In

The gap between bankers' internal estimates and the secondary market is one of the more unusual features of the Anthropic IPO picture. Secondary markets are currently pricing Anthropic at an implied $1 trillion, roughly twice the $400-500 billion range that Goldman Sachs and JPMorgan are reportedly working from internally. That gap is not unusual in late-stage private technology companies, where secondary markets often run ahead of where institutional investors are willing to commit capital in a structured offering.

What is unusual is the size of the gap. A secondary-to-IPO discount of 50 to 60 percent implies that institutional investors either doubt the durability of the current revenue growth rate or are applying a heavier liquidity discount than typical for a company with Anthropic's revenue profile. The bankers' more conservative range may also reflect where they believe the market can absorb a $60 billion raise without suppressing the aftermarket, which would be damaging for employee morale and the company's ability to execute secondary offerings later.

Risks and Open Questions

An October 2026 IPO is not guaranteed. Market conditions, ongoing litigation with the Department of Defense over its supply-chain risk designation, and the possibility that OpenAI reaches public markets first all create scenarios where Anthropic's timeline slips. The D.C. Circuit appeal of the DOD designation is proceeding, with judges having signaled skepticism about the government's position, but a final ruling has not been issued, and unresolved regulatory uncertainty is a factor every underwriter will model in their due-diligence process.

There is also the question of structure. Anthropic is incorporated as a public benefit corporation, which places explicit obligations on the company to weigh societal benefit alongside shareholder returns. Converting or adjusting that structure for a public listing may require shareholder approval and additional regulatory review, adding procedural complexity to the timeline.

For now, the advisory appointments and the October target represent a clear statement of intent. Anthropic has spent three years building a business, then a quarter accelerating revenue at a pace that reset expectations inside and outside the company. Going public would be the next chapter, and the company appears to be taking the first concrete steps toward writing it.